Is miR-223 Upregulation in Inflammatory Bowel Diseases a Protective Response?
Inflammatory bowel diseases (IBD) are characterized by chronic inflammation and damage of colonocytes with etiology of genetic, epigenetic and environmental factors. MicroRNA-223 (miR-223) has been found to be increased in both IBD patients and animal colitis models. However, contentious opinions re...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
IMR Press
2023-02-01
|
| Series: | Frontiers in Bioscience-Elite |
| Subjects: | |
| Online Access: | https://www.imrpress.com/journal/FBE/15/1/10.31083/j.fbe1501005 |